SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jaewook Kim, Yoosoo Yang, Seung Soo Song, Jung-Hyun Na, Kyoung Joon Oh, Cherlhyun Jeong, Yeon Gyu Yu, Yeon-Kyun Shin, Beta-Amyloid Oligomers Activate Apoptotic BAK Pore for Cytochrome c Release, Biophysical Journal, 2014, 107, 7, 1601

    CrossRef

  2. 2
    Saule Kolumbayeva, Dinara Begimbetova, Tamara Shalakhmetova, Timur Saliev, Anna Lovinskaya, Benazir Zhunusbekova, Chromosomal instability in rodents caused by pollution from Baikonur cosmodrome, Ecotoxicology, 2014, 23, 7, 1283

    CrossRef

  3. 3
    Noriaki Nagai, Yoshimasa Ito, Excessive hydrogen peroxide enhances the attachment of amyloid β1–42 in the lens epithelium of UPL rats, a hereditary model for cataracts, Toxicology, 2014, 315, 55

    CrossRef

  4. 4
    Plamena R. Angelova, Andrey Y. Abramov, Interaction of neurons and astrocytes underlies the mechanism of Aβ-induced neurotoxicity, Biochemical Society Transactions, 2014, 42, 5, 1286

    CrossRef

  5. 5
    Chun Shi, XiaoMing Zhu, Jisheng Wang, Dahong Long, Intromitochondrial IκB/NF-κB signaling pathway is involved in amyloid β peptide-induced mitochondrial dysfunction, Journal of Bioenergetics and Biomembranes, 2014, 46, 5, 371

    CrossRef

  6. 6
    Hui Lei, Chun-Yang Zhao, Dong-Mei Liu, Yu Zhang, Lin Li, Xiao-Liang Wang, Ying Peng, l-3-n-Butylphthalide attenuates β-amyloid-induced toxicity in neuroblastoma SH-SY5Y cells through regulating mitochondrion-mediated apoptosis and MAPK signaling, Journal of Asian Natural Products Research, 2014, 16, 8, 854

    CrossRef

  7. 7
    Francesco Angelucci, Francesca Gelfo, Marco Fiore, Nicoletta Croce, Aleksander A. Mathé, Sergio Bernardini, Carlo Caltagirone, The effect of neuropeptide Y on cell survival and neurotrophin expression in in-vitro models of Alzheimer’s disease, Canadian Journal of Physiology and Pharmacology, 2014, 92, 8, 621

    CrossRef

  8. 8
    Xue-Fei Ji, Tian-Yan Chi, Qian Xu, Xiao-Lu He, Xiao-Yu Zhou, Rui Zhang, Li-Bo Zou, Xanthoceraside Ameliorates Mitochondrial Dysfunction Contributing to the Improvement of Learning and Memory Impairment in Mice with Intracerebroventricular Injection of Aβ1-42, Evidence-Based Complementary and Alternative Medicine, 2014, 2014, 1

    CrossRef

  9. 9
    Timothy M. Ryan, Joanne Caine, Haydyn D.T. Mertens, Nigel Kirby, Julie Nigro, Kerry Breheney, Lynne J. Waddington, Victor A. Streltsov, Cyril Curtain, Colin L. Masters, Blaine R. Roberts, Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterization, PeerJ, 2013, 1, e73

    CrossRef

  10. 10
    Le Zhao, Jun-li Wang, Yan-rui Wang, Xiu-zhi Fa, Apigenin attenuates copper-mediated β-amyloid neurotoxicity through antioxidation, mitochondrion protection and MAPK signal inactivation in an AD cell model, Brain Research, 2013, 1492, 33

    CrossRef

  11. 11
    A. Bobba, G. Amadoro, D. Valenti, V. Corsetti, R. Lassandro, A. Atlante, Mitochondrial respiratory chain Complexes I and IV are impaired by β-amyloid via direct interaction and through Complex I-dependent ROS production, respectively, Mitochondrion, 2013, 13, 4, 298

    CrossRef

  12. 12
    Sergio Rosales-Corral, Dario Acuna-Castroviejo, Dun Xian Tan, Gabriela López-Armas, José Cruz-Ramos, Rubén Munoz, Valery G. Melnikov, Lucien C. Manchester, Russel J. Reiter, Accumulation of Exogenous Amyloid-Beta Peptide in Hippocampal Mitochondria Causes Their Dysfunction: A Protective Role for Melatonin, Oxidative Medicine and Cellular Longevity, 2012, 2012, 1

    CrossRef

  13. You have free access to this content13
    Wojciech Danysz, Chris G Parsons, Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine – searching for the connections, British Journal of Pharmacology, 2012, 167, 2
  14. 14
    Sergio A. Rosales-Corral, Dario Acuña-Castroviejo, Ana Coto-Montes, Jose A. Boga, Lucien C. Manchester, Lorena Fuentes-Broto, Ahmet Korkmaz, Shuran Ma, Dun- Xian Tan, Russel J. Reiter, Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin, Journal of Pineal Research, 2012, 52, 2
  15. 15
    Federico Benetti, Stefano Gustincich, Giuseppe Legname, Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits, Expert Opinion on Drug Discovery, 2012, 7, 3, 245

    CrossRef

  16. 16
    Sonia Gandhi, Andrey Y. Abramov, Mechanism of Oxidative Stress in Neurodegeneration, Oxidative Medicine and Cellular Longevity, 2012, 2012, 1

    CrossRef

  17. 17
    Russell H. Swerdlow, Mitochondria and Cell Bioenergetics: Increasingly Recognized Components and a Possible Etiologic Cause of Alzheimer's Disease, Antioxidants & Redox Signaling, 2012, 16, 12, 1434

    CrossRef

  18. 18
    María Morán, David Moreno-Lastres, Lorena Marín-Buera, Joaquín Arenas, Miguel A. Martín, Cristina Ugalde, Mitochondrial respiratory chain dysfunction: Implications in neurodegeneration, Free Radical Biology and Medicine, 2012, 53, 3, 595

    CrossRef

  19. 19
    Rui Liu, Cai-xia Wu, Dan Zhou, Fan Yang, Shuo Tian, Li Zhang, Tian-tai Zhang, Guan-hua Du, Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis, BMC Medicine, 2012, 10, 1, 105

    CrossRef

  20. 20
    Anju S. Samy, Orisa J. Igwe, Regulation of IL-1β-Induced Cyclooxygenase-2 Expression by Interactions of Aβ Peptide, Apolipoprotein E and Nitric Oxide in Human Neuroglioma, Journal of Molecular Neuroscience, 2012, 47, 3, 533

    CrossRef

  21. 21
    Bruce L. Kagan, Molecular Biology of Neurodegenerative Diseases, 2012,

    CrossRef

  22. 22
    R. Abeti, A. Y. Abramov, M. R. Duchen,  -amyloid activates PARP causing astrocytic metabolic failure and neuronal death, Brain, 2011, 134, 6, 1658

    CrossRef

  23. 23
    Heng Du, Lan Guo, Wensheng Zhang, Monika Rydzewska, Shidu Yan, Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model, Neurobiology of Aging, 2011, 32, 3, 398

    CrossRef

  24. 24
    N. Dragicevic, P.C. Bradshaw, M. Mamcarz, X. Lin, L. Wang, C. Cao, G.W. Arendash, Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit?, Neuroscience, 2011, 185, 135

    CrossRef

  25. 25
    Nicoletta Croce, Vincenzo Dinallo, Valerio Ricci, Giorgio Federici, Carlo Caltagirone, Sergio Bernardini, Francesco Angelucci, Neuroprotective Effect of Neuropeptide Y against Beta-Amyloid 25–35 Toxicity in SH-SY5Y Neuroblastoma Cells Is Associated with Increased Neurotrophin Production, Neurodegenerative Diseases, 2011, 8, 5, 300

    CrossRef

  26. 26
    Zhiyou Cai, Bin Zhao, Anna Ratka, Oxidative Stress and β-Amyloid Protein in Alzheimer’s Disease, NeuroMolecular Medicine, 2011, 13, 4, 223

    CrossRef

  27. 27
    Elena Kosenko, Armenuhi Poghosyan, Yury Kaminsky, Subcellular compartmentalization of proteolytic enzymes in brain regions and the effects of chronic β-amyloid treatment, Brain Research, 2011, 1369, 184

    CrossRef

  28. 28
    M. Ueno, T. Nakagawa, Y. Nagai, N. Nishi, T. Kusaka, K. Kanenishi, M. Onodera, N. Hosomi, C. Huang, H. Yokomise, H. Tomimoto, H. Sakamoto, The expression of CD36 in vessels with blood–brain barrier impairment in a stroke-prone hypertensive model, Neuropathology and Applied Neurobiology, 2011, 37, 7
  29. 29
    Heng Du, Shirley ShiDu Yan, Mitochondrial permeability transition pore in Alzheimer's disease: Cyclophilin D and amyloid beta, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010, 1802, 1, 198

    CrossRef

  30. 30
    Yury G. Kaminsky, Michael W. Marlatt, Mark A. Smith, Elena A. Kosenko, Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35, Experimental Neurology, 2010, 221, 1, 26

    CrossRef

  31. 31
    Alfonso Díaz, Luis De Jesús, Liliana Mendieta, Minerva Calvillo, Blanca Espinosa, Edgar Zenteno, Jorge Guevara, Ilhuicamina Daniel Limón, The amyloid-β25–35 injection into the CA1 region of the neonatal rat hippocampus impairs the long-term memory because of an increase of nitric oxide, Neuroscience Letters, 2010, 468, 2, 151

    CrossRef

  32. 32
    Masaki Ueno, Bin Wu, Toshitaka Nakagawa, Yukiko Nagai, Masayuki Onodera, Cheng-long Huang, Takashi Kusaka, Kenji Kanenishi, Haruhiko Sakamoto, The expression of LDL receptor in vessels with blood–brain barrier impairment in a stroke-prone hypertensive model, Histochemistry and Cell Biology, 2010, 133, 6, 669

    CrossRef

  33. 33
    I. Daniel Limón, Alfonso Díaz, Liliana Mendieta, Germán Chamorro, Blanca Espinosa, Edgar Zenteno, Jorge Guevara, Amyloid-β25–35 impairs memory and increases NO in the temporal cortex of rats, Neuroscience Research, 2009, 63, 2, 129

    CrossRef

  34. 34
    Jolanta Dorszewska, Bartosz Kempisty, Joanna Jaroszewska-Kolecka, Agata Różycka, Jolanta Florczak, Margarita Lianeri, Paweł P. Jagodziński, Wojciech Kozubski, Expression and Polymorphisms of Gene 8-Oxoguanine Glycosylase 1 and the Level of Oxidative DNA Damage in Peripheral Blood Lymphocytes of Patients with Alzheimer's Disease, DNA and Cell Biology, 2009, 28, 11, 579

    CrossRef

  35. 35
    Robert D. Bell, Berislav V. Zlokovic, Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease, Acta Neuropathologica, 2009, 118, 1, 103

    CrossRef

  36. 36
    Yong Kyung Lee, Dong Yeon Yuk, Tae Il Kim, Young Heui Kim, Kyoung Tae Kim, Ki Ho Kim, Beom Jun Lee, Sang-Yoon Nam, Jin Tae Hong, Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity, Journal of Natural Medicines, 2009, 63, 3, 274

    CrossRef

  37. 37
    Fang Fang, Geng-tao Liu, Protective effects of compound FLZ, a novel synthetic analogue of squamosamide, on β-amyloid-induced rat brain mitochondrial dysfunction in vitro, Acta Pharmacologica Sinica, 2009, 30, 5, 522

    CrossRef

  38. 38
    Catherine Strazielle, Rozat Jazi, Yann Verdier, Sue Qian, Robert Lalonde, Regional brain metabolism with cytochrome c oxidase histochemistry in a PS1/A246E mouse model of autosomal dominant Alzheimer's disease: Correlations with behavior and oxidative stress, Neurochemistry International, 2009, 55, 8, 806

    CrossRef

  39. 39
    Chi-Huan Chang, Chiung-Huei Peng, Kuan-Chou Chen, Hsien-Bin Huang, Wen-Ta Chiu, Robert Y. Peng, Shock membrane electropotential drops and limited diffusive distance of β-amyloids in cerebral neurons are detrimental enhancement to Alzheimer's diseases, Colloids and Surfaces B: Biointerfaces, 2009, 73, 2, 339

    CrossRef

  40. 40
    Phullara B. Shelat, Malgorzata Chalimoniuk, Jing-Hung Wang, Joanna B. Strosznajder, James C. Lee, Albert Y. Sun, Agnes Simonyi, Grace Y. Sun, Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons, Journal of Neurochemistry, 2008, 106, 1
  41. 41
    Jonathan J. Abbott, David R. Howlett, Paul T. Francis, Robert J. Williams, Aβ1–42 modulation of Akt phosphorylation via α7 nAChR and NMDA receptors, Neurobiology of Aging, 2008, 29, 7, 992

    CrossRef

  42. 42
    S M Jin, H J Cho, E S Jung, M-Y Shim, I Mook-Jung, DNA damage-inducing agents elicit γ-secretase activation mediated by oxidative stress, Cell Death and Differentiation, 2008, 15, 9, 1375

    CrossRef

  43. 43
    Jon Nilsen, Estradiol and neurodegenerative oxidative stress, Frontiers in Neuroendocrinology, 2008, 29, 4, 463

    CrossRef

  44. 44
    José R. Lopez, Alvin Lyckman, Salvatore Oddo, Frank M. LaFerla, Henry W. Querfurth, Alexander Shtifman, Increased intraneuronal resting [Ca2+] in adult Alzheimer’s disease mice, Journal of Neurochemistry, 2008, 105, 1
  45. 45
    Peter J. Crouch, Susan-Marie E. Harding, Anthony R. White, James Camakaris, Ashley I. Bush, Colin L. Masters, Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease, The International Journal of Biochemistry & Cell Biology, 2008, 40, 2, 181

    CrossRef

  46. 46
    Ju Yeon Ban, Ha Thi Thuy Nguyen, Hee-Ju Lee, Soon Ock Cho, Hyun Soo Ju, Ju Yeon Kim, KiHwan Bae, Kyung-Sik Song, Yeon Hee Seong, Neuroprotective Properties of Gallic Acid from Sanguisorbae Radix on Amyloid β Protein (25—35)-Induced Toxicity in Cultured Rat Cortical Neurons, Biological & Pharmaceutical Bulletin, 2008, 31, 1, 149

    CrossRef

  47. 47
    Ju Yeon Ban, Soon Ock Cho, So-Young Jeon, KiHwan Bae, Kyung-Sik Song, Yeon Hee Seong, 3,4-Dihydroxybenzoic acid from Smilacis chinae rhizome protects amyloid β protein (25–35)-induced neurotoxicity in cultured rat cortical neurons, Neuroscience Letters, 2007, 420, 2, 184

    CrossRef

  48. 48
    Won Kyung Hong, Eun Hae Han, Dae Ghon Kim, Jung Yup Ahn, Jeong Soon Park, Bok Ghee Han, Amyloid-β-Peptide Reduces the Expression Level of Mitochondrial Cytochrome Oxidase Subunits, Neurochemical Research, 2007, 32, 9, 1483

    CrossRef

  49. 49
    E. Burgos-Ramos, A. Hervás-Aguilar, L. Puebla-Jiménez, M.C. Boyano-Adánez, E. Arilla-Ferreiro, Chronic but not acute intracerebroventricular administration of amyloid β-peptide(25–35) decreases somatostatin content, adenylate cyclase activity, somatostatin-induced inhibition of adenylate cyclase activity, and adenylate cyclase I levels in the rat hippocampus, Journal of Neuroscience Research, 2007, 85, 2
  50. 50
    Jianlin Wu, Ghous M. Khan, Robert A. Nichols, Dopamine release in prefrontal cortex in response to β-amyloid activation of α7∗ nicotinic receptors, Brain Research, 2007, 1182, 82

    CrossRef

  51. 51
    P.J. Crouch, K. Cimdins, J.A. Duce, A.I. Bush, I.A. Trounce, Mitochondria in Aging and Alzheimer's Disease, Rejuvenation Research, 2007, 10, 3, 349

    CrossRef

  52. 52
    A. Y. Abramov, C. Fraley, C. T. Diao, R. Winkfein, M. A. Colicos, M. R. Duchen, R. J. French, E. Pavlov, Targeted polyphosphatase expression alters mitochondrial metabolism and inhibits calcium-dependent cell death, Proceedings of the National Academy of Sciences, 2007, 104, 46, 18091

    CrossRef

  53. 53
    Peter J. Crouch, Kevin J. Barnham, James A. Duce, Rachel E. Blake, Colin L. Masters, Ian A. Trounce, Copper-dependent inhibition of cytochrome c oxidase by Aβ1−42 requires reduced methionine at residue 35 of the Aβ peptide, Journal of Neurochemistry, 2006, 99, 1
  54. 54
    Homira Behbahani, Irina G. Shabalina, Birgitta Wiehager, Hérnan Concha, Kjell Hultenby, Natasa Petrovic, Jan Nedergaard, Bengt Winblad, Richard F. Cowburn, Maria Ankarcrona, Differential role of presenilin-1 and -2 on mitochondrial membrane potential and oxygen consumption in mouse embryonic fibroblasts, Journal of Neuroscience Research, 2006, 84, 4
  55. 55
    Daniela Puzzo, Agostino Palmeri, Ottavio Arancio, Involvement of the Nitric Oxide Pathway in Synaptic Dysfunction Following Amyloid Elevation in Alzheimer's Disease, Reviews in the Neurosciences, 2006, 17, 5

    CrossRef

  56. 56
    Kazuhiro Takuma, Mitochondrial dysfunction and apoptosis in neurodegenerative diseases, Folia Pharmacologica Japonica, 2006, 127, 5, 349

    CrossRef

  57. 57
    Colin L. Masters, Roberto Cappai, Kevin J. Barnham, Victor L. Villemagne, Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics, Journal of Neurochemistry, 2006, 97, 6
  58. 58
    Salvador Moncada, Juan P. Bolaños, Nitric oxide, cell bioenergetics and neurodegeneration, Journal of Neurochemistry, 2006, 97, 6
  59. 59
    Christiane Massicotte, Kristin Knight, Cornelis J. Van Der Schyf, Bernard S. Jortner, Marion Ehrich, Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells, Neurotoxicity Research, 2005, 7, 3, 203

    CrossRef

  60. 60
    Jan Mulder, Tibor Harkany, Katalin Czollner, Thomas I.F.H. Cremers, Jan N. Keijser, Csaba Nyakas, Paul G.M. Luiten, Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum, Behavioural Brain Research, 2005, 163, 1, 33

    CrossRef

  61. 61
    Laurent Lecanu, Wenguo Yao, Alexander Piechot, Janet Greeson, Dimitrios Tzalis, Vassilios Papadopoulos, Identification, design, synthesis, and pharmacological activity of (4-ethyl-piperazin-1-yl)-phenylmethanone derivatives with neuroprotective properties against β-amyloid-induced toxicity, Neuropharmacology, 2005, 49, 1, 86

    CrossRef

  62. 62
    Sun Young Lee, Jae Woong Lee, Heesoon Lee, Han Soo Yoo, Yeo Pyo Yun, Ki Wan Oh, Tae Youl Ha, Jin Tae Hong, Inhibitory effect of green tea extract on β-amyloid-induced PC12 cell death by inhibition of the activation of NF-κB and ERK/p38 MAP kinase pathway through antioxidant mechanisms, Molecular Brain Research, 2005, 140, 1-2, 45

    CrossRef

  63. 63
    Laurent Lecanu, Yao Wenguo, Jing Xu, Janet Greeson, Vassilios Papadopoulos, Local Anesthetic Procaine Protects Rat Pheochromocytoma PC12 Cells against β-Amyloid-Induced Neurotoxicity, Pharmacology, 2005, 74, 2, 65

    CrossRef

  64. 64
    Elisa Mitiko Kawamoto, Carolina Demarchi Munhoz, Isaias Glezer, Valéria Santoro Bahia, Paulo Caramelli, Ricardo Nitrini, Renata Gorjão, Rui Curi, Cristoforo Scavone, Tania Marcourakis, Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease, Neurobiology of Aging, 2005, 26, 6, 857

    CrossRef

  65. 65
    Irina G. Stavrovskaya, Bruce S. Kristal, The powerhouse takes control of the cell: Is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death?, Free Radical Biology and Medicine, 2005, 38, 6, 687

    CrossRef

  66. 66
    Hyo-Jin Park, Young-Mo Seong, Ju-Youn Choi, Seongman Kang, Hyangshuk Rhim, Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi, Neuroscience Letters, 2004, 357, 1, 63

    CrossRef

  67. 67
    Mikhail Yu. Stepanichev, Irina M. Zdobnova, Irina I. Zarubenko, Yulia V. Moiseeva, Natalia A. Lazareva, Mikhail V. Onufriev, Natalia V. Gulyaeva, Amyloid-β(25–35)-induced memory impairments correlate with cell loss in rat hippocampus, Physiology & Behavior, 2004, 80, 5, 647

    CrossRef

  68. 68
    Mildred S. Seelig, Burton M. Altura, Bella T. Altura, Benefits and Risks of Sex Hormone Replacement in Postmenopausal Women, Journal of the American College of Nutrition, 2004, 23, 5, 482S

    CrossRef

  69. 69
    Corinna Van Den Heuvel, James J. Donkin, John W. Finnie, Peter C. Blumbergs, Tim Kuchel, Barbara Koszyca, Jim Manavis, Nigel R. Jones, Peter L. Reilly, Robert Vink, Downregulation of Amyloid Precursor Protein (APP) Expression following Post-Traumatic Cyclosporin-A Administration, Journal of Neurotrauma, 2004, 21, 11, 1562

    CrossRef

  70. 70
    F Misiti, G.E Martorana, G Nocca, E Di Stasio, B Giardina, M.E Clementi, Methionine 35 oxidation reduces toxic and pro-apoptotic effects of the amyloid β-protein fragment (31–35) on isolated brain mitochondria, Neuroscience, 2004, 126, 2, 297

    CrossRef

  71. 71
    Francisca Pérez-Severiano, Raquel Salvatierra-Sánchez, Mayra Rodrı́guez-Pérez, Elvis Y Cuevas-Martı́nez, Jorge Guevara, Daniel Limón, Perla D Maldonado, Omar N Medina-Campos, José Pedraza-Chaverrı́, Abel Santamarı́a, S-Allylcysteine prevents amyloid-β peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits, European Journal of Pharmacology, 2004, 489, 3, 197

    CrossRef

  72. 72
    Bernard G. Schreurs, Carrie A. Smith-Bell, Jeff Lochhead, D. Larry Sparks, Cholesterol Modifies Classical Conditioning of the Rabbit (Oryctolagus cuniculus) Nictitating Membrane Response., Behavioral Neuroscience, 2003, 117, 6, 1220

    CrossRef

  73. 73
    Anne Eckert, Uta Keil, Celio A. Marques, Astrid Bonert, Claudia Frey, Katrin Schüssel, Walter E. Müller, Mitochondrial dysfunction, apoptotic cell death, and Alzheimer’s disease, Biochemical Pharmacology, 2003, 66, 8, 1627

    CrossRef

  74. 74
    C Strazielle, C Sturchler-Pierrat, M Staufenbiel, R Lalonde, Regional brain cytochrome oxidase activity in β-amyloid precursor protein transgenic mice with the swedish mutation, Neuroscience, 2003, 118, 4, 1151

    CrossRef

  75. 75
    Yoshifumi Irie, Wing Ming Keung, Rhizoma acori graminei and its active principles protect PC-12 cells from the toxic effect of amyloid-β peptide, Brain Research, 2003, 963, 1-2, 282

    CrossRef

  76. 76
    Steven W Barger, Non-Neuronal Cells of the Nervous System: Function and Dysfunction, 2003,

    CrossRef

  77. 77
    Hye-Sun Kim, Jun-Ho Lee, Jean-Pyo Lee, Eun-Mee Kim, Keun-A Chang, Cheol Hyoung Park, Sung-Jin Jeong, M. C. Wittendorp, Ji-Heui Seo, Se-Hoon Choi, Yoo-Hun Suh, Amyloid ?? peptide induces cytochrome c release from isolated mitochondria, NeuroReport, 2002, 13, 15, 1989

    CrossRef

  78. 78
    Paula I. Moreira, Maria S. Santos, António Moreno, A. Cristina Rego, Catarina Oliveira, Effect of amyloid β-peptide on permeability transition pore: A comparative study, Journal of Neuroscience Research, 2002, 69, 2
  79. 79
    BARRY HALLIWELL, Hypothesis: Proteasomal Dysfunction, Annals of the New York Academy of Sciences, 2002, 962, 1
  80. 80
    Nicole A. Abramova, David S. Cassarino, Shaharyar M. Khan, Terry W. Painter, James P. Bennett, Inhibition by R(+) or S(–) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma, Journal of Neuroscience Research, 2002, 67, 4
  81. 81
    V. Calabrese, G. Scapagnini, A. Ravagna, R.G. Fariello, A.M. Giuffrida Stella, N.G. Abraham, Regional distribution of heme oxygenase, HSP70, and glutathione in brain: Relevance for endogenous oxidant/antioxidant balance and stress tolerance, Journal of Neuroscience Research, 2002, 68, 1
  82. 82
    Rai Ajit K. Srivastava, Jinesh C. Jain, Scavenger receptor class B type I expression and elemental analysis in cerebellum and parietal cortex regions of the Alzheimer's disease brain, Journal of the Neurological Sciences, 2002, 196, 1-2, 45

    CrossRef

  83. 83
    C. S. Casley, L. Canevari, J. M. Land, J. B. Clark, M. A. Sharpe, β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities, Journal of Neurochemistry, 2002, 80, 1
  84. 84
    John P. Blass, Glucose Metabolism in the Brain, 2002,

    CrossRef

  85. 85
    D.Allan Butterfield, Jennifer Drake, Chava Pocernich, Alessandra Castegna, Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide, Trends in Molecular Medicine, 2001, 7, 12, 548

    CrossRef